Using a model-based geostatistical approach to design and analyse the prevalence of schistosomiasis in Kenya

• Published in: Frontiers in Tropical Diseases
• Main Authors: Collins Okoyo, Mark Minnery, Idah Orowe, Chrispin Owaga, Christin Wambugu, Nereah Olick, Jane Hagemann, Wyckliff P. Omondi, Paul M. Gichuki, Kate McCracken, Antonio Montresor, Claudio Fronterre, Peter Diggle, Charles Mwandawiro
• Format: Article in Journal/Newspaper
• Language: English
• Published: Frontiers Media S.A. 2023
• Subjects: schistosomiasis; Schistosoma mansoni; Schistosoma haematobium; model-based geostatistics; modelling; national school-based deworming; Arctic medicine. Tropical medicine; RC955-962; Arctic
• Online Access: https://doi.org/10.3389/fitd.2023.1240617; https://doaj.org/article/e3828870f76a4940896c7c69d07bd5f7

BackgroundInfections caused by both Schistosoma mansoni and Schistosoma haematobium are endemic in Kenya, with over six million children at risk. A national school-based deworming programme was launched in 2012 with the goal of eliminating parasitic worms as a public health problem. This study used a model-based geostatistical (MBG) approach to design and analyse the impact of the programme and inform treatment strategy changes for schistosomiasis (SCH).MethodsA cross-sectional survey of 200 schools across 27 counties of Kenya was utilised. The study design, selection of the schools, and analysis followed the MBG approach, which incorporated historical data on treatment, morbidity, and environmental covariates.ResultsThe overall SCH prevalence was 5.0% (95% CI 4.9%–5.2%) and was estimated, with a high predictive probability of 0.999, to be between 1% and< 10%. The predictive probabilities at county level revealed county heterogeneity, with that of four counties estimated to be between 0% and< 1%, that of 20 counties estimated to be between 1% and< 10%, that of two counties estimated to be between 10% and< 20%, and that of one county estimated to be between 20% and< 50%.ConclusionSCH treatment requirements can now be confidently refined based on the World Health Organization’s guidelines. The four counties with prevalences of between 0% and< 1% may consider suspending treatment only in areas (i.e., sub-counties and wards) where the prevalence is< 1%.